Lv3
240 积分 2026-01-06 加入
SGLT2is Versus Metformin for Delirium Prevention in Type 2 Diabetes: A Real-World, Head- to-Head Comparative Study
1个月前
已完结
Comment on Buse et al. Prevalence of Hypercortisolism in Difficult-to-Control Type 2 Diabetes. Diabetes Care 2025;48:2012–2020
1个月前
已完结
Comment on Sun et al. SGLT2i Versus Metformin for Delirium Prevention in Type 2 Diabetes: A Real-World, Head-to-Head Comparative Study. Diabetes Care 2025;48:1361–1369
1个月前
已完结
Sodium–Glucose Co-transporter 2 Inhibitors treatment improve pancreatic β-cells function and insulin resistance in patients with Type 2 diabetes
5个月前
已完结
Comparative safety and efficacy analysis of GLP-1 receptor agonists and SGLT-2 inhibitors among frail individuals with type 2 diabetes in the era of continuous population ageing
5个月前
已完结
Effect of newer glucose-lowering medications on chronic obstructive pulmonary disease exacerbations among individuals with type 2 diabetes
5个月前
已完结
Nonarteritic anterior ischemic optic neuropathy and glucagon-like peptide-1 receptor agonists: Evaluating a potential association
5个月前
已完结
Association of social isolation with excess mortality risk and life expectancy in people with prediabetes and diabetes
5个月前
已完结
Sodium-glucose cotransporter 2 inhibitors may increase iron availability with beneficial effects on erythropoiesis and cardiovascular mortality in patients with type 2 diabetes mellitus
5个月前
已完结
Sodium-glucose cotransporter 2 inhibitors may increase iron availability with beneficial effects on erythropoiesis and cardiovascular mortality in patients with type 2 diabetes mellitus. Author’s Reply
5个月前
已关闭
皖公网安备34019202002308
